• Mashup Score: 8

    Access this webinar on The EAPCI Journal Club: the TRILUMINATE trial and more with Professor E. Barbato (Italy,IT),Mr E. Rafflenbeul (Germany,DE), Doctor J. Curio (Germany,DE),Professor P. Lurz (Germany,DE).

    Tweet Tweets with this article
    • RT @KardiologieHH: 🚨3 hours to go… …FIRST #EAPCI Journal Club❗️ 🎯Still time to register for free: 🔗 https://t.co/Jw9A7ERQe3 Be part of th…

    • 🚨3 hours to go… …FIRST #EAPCI Journal Club❗️ 🎯Still time to register for free: 🔗 https://t.co/Jw9A7ERQe3 Be part of the #EAPCI JC and join the discussion of the #TRILUMINATE trial👍 https://t.co/qh05j9v8Bj

  • Mashup Score: 6

    ACC Member Care is available to assist you with any questions you may have when using ACC.org. Representatives are available Monday-Friday, 9:00 a.m.-5:00 p.m. (Eastern Time). You can reach the ACC Member Care Team by phone at 800-253-4636 (Toll Free US & Canada); 202-375-6000 (Outside US & Canada); Fax: 202-375-7000; or by Email at membercare@acc.org ACC Member Care The American College of…

    Tweet Tweets with this article
    • Thanks to all @ACCinTouch members who generated interesting discussions around #ACC23 #LBCT on #DocMatter! #RenovateComplexPCI #TRILUMINATE & more.. #ACCIC #ACCEarlyCareer #ACCFIT If u haven’t used it yet, u can check out #DocMatter here: https://t.co/MEw45wqINx… https://t.co/aPX1wEoDfp

  • Mashup Score: 0

    March 4, 2023 — Findings from the TRILUMINATE Pivotal Trial found no significant difference in survival or hospitalization after one year of follow-up, according to research presented on the first day of the American College of Cardiology’s Annual Scientific Session Together with the World Congress of Cardiology ACC.23/WCC. A presentation of findings during the first Late Breaking session…

    Tweet Tweets with this article
    • @DAICeditor @AbbottCardio Findings from the #TRILUMINATE #Pivotal_trial found no significant difference in survival or hospitalization after one year of follow-up, according to research presented on the first day of the #Acc23 #wcc23 in New Orleans: https://t.co/yQV2yCQrda

  • Mashup Score: 6

    Drs. Michael Gibson, Rasha Al-Lamee and Javed Butler review the Day 1 late-breaking science from ACC.23, including CLEAR OUTCOMES (0:21), TRILUMINATE (2:13) and STOP CA (5:05). The ACC is providing coverage of the hottest ACC.23 science. For trial summaries, news coverage, daily video wrap-ups and more, visit ACC’s Meeting Coverage page and follow the ACC on social media using #ACC23. …

    Tweet Tweets with this article
    • Drs. @CMichaelGibson, @rallamee, and @JavedButler1 review the Day 1️⃣ LBCTs from #ACC23/#WCCardio, including #CLEAR OUTCOMES, #TRILUMINATE, and STOP-CA. 🔗 https://t.co/nB6dRtBHPe @ACCinTouch #ACCessPoints #CardioTwitter #CardioEd https://t.co/5hMecjDQFE

    • Watch the #ACCessPoints Daily Wrap Up video where Drs. @CMichaelGibson, @rallamee & @JavedButler1 review the late-breaking science from today! 📽️https://t.co/j0ZES0ObYy #CardioTwitter https://t.co/JeutnyyMth

  • Mashup Score: 1
    (1) Post | LinkedIn - 1 year(s) ago

    Univ.-Prof.Dr. Ralph Stephan von Bardeleben Univ.-Professor Interv. Klappentherapie, Head Heart Valve Center, Editor in Chief Echocardiography, Full Professor Interventional Heart Valve Tx Cardiology JGU University of Mainz, ACHD EMAH View full profile

    Tweet Tweets with this article
    • #Triluminate #Trial #Data #RCT and the #NewFrontier of #Tricuspid #heartvalve #repair at #PCRLV in late 2022 see more at https://t.co/UKhF0i6WVN https://t.co/S0Ie8Gayw1